MPN Survivor Discusses Her Biggest Regret After Being Diagnosed

News
Video

After being diagnosed with essential thrombocythemia, Marilyn Kay Edwards was not told much about her disease.

When Marilyn Kay Edwards was diagnosed with essential thrombocythemia in 1986, she was told to just continue living her life. Doctors told Edwards, who was pregnant at the time, to continue taking aspirin and watch the pregnancy, and get her blood checked every year to a year and a half. In fact, at that time, myeloproliferative neoplasms (MPNs) like essential thrombocythemia were not even classified as cancers.

Edwards said that she was not told that her essential thrombocythemia could turn into a more serious type of MPN called myelofibrosis, which she was later diagnosed with in 2017. In a recent interview with CURE®, she expressed that she wishes she was more involved with her care and learned more about her disease. She said if she had been, then she could have potentially started treatments for her disease.

Now, Edwards is an MPN Peer with the Voices of MPN CHAMPN program and recently was honored at CURE®’s 11th annual MPN Heroes® recognition event. She uses her experience to help guide others who recently received a diagnosis of an MPN.

READ MORE:CURE Celebrates 8 Honorees at MPN Heroes Event

Transcription

I've learned that I should have been more involved in my diagnosis because I did not understand what I had at all. And I just kind of kept my head in the sand. And then in 2017, I got very sick and whenever they told me what was wrong, I had never heard of it before. And then when you Google it, it's not good.

So, I've learned to tell people “Don't Google myelofibrosis.” And I should have been more involved with what was happening. That's probably my biggest regret because I actually missed out on treatments that I could have had earlier that I didn't know about.


For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
A man with a dark gray button-up shirt with glasses and cropped brown hair.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Man in a navy suit with a purple tie. Dr. Saby George talks to CURE about how treatment with Opdivo could mitigate disparities in patients with kidney cancer.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Related Content